Bio Retained Earnings vs Total Current Liabilities Analysis
BPTH Stock | USD 2.06 0.13 6.74% |
Bio Path financial indicator trend analysis is way more than just evaluating Bio Path Holdings prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bio Path Holdings is a good investment. Please check the relationship between Bio Path Retained Earnings and its Total Current Liabilities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Retained Earnings vs Total Current Liabilities
Retained Earnings vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bio Path Holdings Retained Earnings account and Total Current Liabilities. At this time, the significance of the direction appears to have pay attention.
The correlation between Bio Path's Retained Earnings and Total Current Liabilities is -0.94. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Bio Path Holdings, assuming nothing else is changed. The correlation between historical values of Bio Path's Retained Earnings and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Bio Path Holdings are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Retained Earnings i.e., Bio Path's Retained Earnings and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | -0.94 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Total Current Liabilities
Total Current Liabilities is an item on Bio Path balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bio Path Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Bio Path's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bio Path Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. The Bio Path's current Sales General And Administrative To Revenue is estimated to increase to 179.88, while Selling General Administrative is projected to decrease to under 2.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Net Interest Income | 3K | 33K | 52K | 32.5K | Interest Income | 3K | 33K | 52K | 31.0K |
Bio Path fundamental ratios Correlations
Click cells to compare fundamentals
Bio Path Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bio Path fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 22.7M | 16.5M | 26.6M | 16.0M | 3.2M | 3.1M | |
Other Current Liab | 673K | 975K | 770K | 909K | 1.3M | 1.4M | |
Total Current Liabilities | 1.2M | 1.2M | 958K | 1.7M | 1.9M | 2.0M | |
Total Stockholder Equity | 21.1M | 15.1M | 25.5M | 14.2M | 441K | 419.0K | |
Property Plant And Equipment Net | 670K | 519K | 428K | 356K | 178K | 344.7K | |
Net Debt | (20.0M) | (13.4M) | (23.5M) | (10.2M) | (939K) | (986.0K) | |
Retained Earnings | (56.3M) | (67.2M) | (77.7M) | (91.5M) | (107.6M) | (102.2M) | |
Accounts Payable | 486K | 100K | 106K | 667K | 457K | 479.9K | |
Cash | 20.4M | 13.8M | 23.8M | 10.4M | 1.1M | 999.4K | |
Non Current Assets Total | 670K | 519K | 428K | 356K | 178K | 169.1K | |
Non Currrent Assets Other | (13.4M) | 288K | 225K | 158K | 76K | 79.8K | |
Cash And Short Term Investments | 20.4M | 13.8M | 23.8M | 10.4M | 1.1M | 999.4K | |
Common Stock Shares Outstanding | 132.9K | 192.4K | 336.3K | 363.8K | 478K | 292.6K | |
Liabilities And Stockholders Equity | 22.7M | 16.5M | 26.6M | 16.0M | 3.2M | 3.1M | |
Non Current Liabilities Total | 330K | 236K | 153K | 113K | 873K | 916.7K | |
Other Current Assets | 788K | 2.2M | 2.4M | 5.2M | 2.0M | 2.1M | |
Other Stockholder Equity | 77.4M | 82.3M | 103.1M | 105.7M | 108.0M | 113.4M | |
Total Liab | 1.6M | 1.4M | 1.1M | 1.8M | 2.8M | 2.9M | |
Property Plant And Equipment Gross | 670K | 519K | 1.3M | 1.3M | 1.2M | 1.3M | |
Total Current Assets | 22.0M | 16.0M | 26.1M | 15.6M | 3.0M | 2.9M | |
Common Stock | 1K | 4K | 5K | 7K | 8K | 950.0 | |
Common Stock Total Equity | 11K | 1K | 4K | 5K | 4.5K | 4.3K | |
Net Tangible Assets | 1.2M | 21.1M | 15.1M | 25.5M | 29.3M | 30.7M | |
Retained Earnings Total Equity | (39.2M) | (47.7M) | (56.3M) | (67.2M) | (60.5M) | (57.5M) | |
Capital Surpluse | 47.2M | 49.0M | 77.4M | 82.3M | 94.6M | 99.4M | |
Property Plant Equipment | 406K | 303K | 231K | 428K | 492.2K | 282.1K | |
Accumulated Depreciation | (330K) | (592K) | (726K) | (798K) | (718.2K) | (682.3K) | |
Net Invested Capital | 21.1M | 15.1M | 25.5M | 14.2M | 441K | 419.0K | |
Net Working Capital | 20.7M | 14.8M | 25.2M | 13.9M | 1.1M | 1.1M |
Currently Active Assets on Macroaxis
When determining whether Bio Path Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Path's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Path Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Path Holdings Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Bio Stock analysis
When running Bio Path's price analysis, check to measure Bio Path's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Path is operating at the current time. Most of Bio Path's value examination focuses on studying past and present price action to predict the probability of Bio Path's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Path's price. Additionally, you may evaluate how the addition of Bio Path to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Bio Path's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Path. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Path listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (25.26) | Return On Assets (1.38) | Return On Equity (4.31) |
The market value of Bio Path Holdings is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Path's value that differs from its market value or its book value, called intrinsic value, which is Bio Path's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Path's market value can be influenced by many factors that don't directly affect Bio Path's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Path's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Path is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Path's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.